The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Hargreaves Lansdown falls on higher costs warning

Mon, 09th Aug 2021 08:49

(Alliance News) - Stock prices in London opened lower on Monday as investors grew more concerned over the spread of the Delta variant of Covid-19, while Hargreaves Lansdown shares slipped after warning on higher costs and earnings missing forecasts.

The FTSE 100 index was down 13.70 points, or 0.2%, at 7,109.25. The mid-cap FTSE 250 index was down 71.66 points, or 0.3%, at 23,385.66. The AIM All-Share index was down 0.2% at 1,259.76.

The Cboe UK 100 index was down 0.2% at 708.30. The Cboe 250 was down 0.4% at 21,180.35, and the Cboe Small Companies flat at 15,405.34.

In mainland Europe, the CAC 40 in Paris and DAX 30 in Frankfurt were both up 0.1%.

In the FTSE 100, AstraZeneca was up 0.8% after Morgan Stanley resumed coverage on the Anglo-Swedish drugmaker with an Overweight rating. In addition, AstraZeneca said it Forxiga drug was approved in the EU for treatment of chronic kidney disease.

At the other end of the large-caps, Hargreaves Lansdown was the worst performer, down 8.8%, even as the fund supermarket reported positive annual results.

For the financial year that ended June 30, revenue rose 15% to GBP631.0 million from GBP550.9 million last year, but pretax profit was GBP366.0 million, down 3.0% from GBP378.3 million. The revenue and profit figures missed consensus estimates from Jefferies of GBP636.7 billion and GBP383.0 million respectively.

The Bristol-based firm reported strong growth in assets under administration, which were up 30% to GBP135.5 billion from GBP104.0 billion. Net new business inflows were up 13% to GBP8.7 billion from GBP7.7 billion. However, this also missed Jefferies forecasts of GBP136.3 billion and GBP9.2 billion respectively.

Looking ahead, Chief Executive Officer Chris Hill said: "With this continued investment in our people, proposition, service and technology as well as the cost of servicing an enlarged and growing client base, we expect 2022 costs to reflect this investment and continue to be broadly aligned to client growth."

Hargreaves Lansdown also warned it has seen a slowdown in dealing volumes and client activity versus the elevated levels at the time last year.

"While market share increased marginally and retention remains 92% on a client numbers and AUA basis, the problem of having more, less profitable, clients is emerging. With new and aggressive competitors joining the UK market, revenue margins falling and costs rising, financial 2022 will see these trends continue. Despite strong client recruitment and retention and clear market leadership, we think HL may be vulnerable," said analysts at Jefferies.

In the FTSE 250, Vectura Group was up 2.3% at 167.80 pence after Philip Morris International raised its bid for asthma treatment firm to 165 pence per share.

The Marlboro cigarette maker's offer bested the 155p offer from private equity firm Carlyle to which Vectura had agreed on Friday. The new offer values Vectura at GBP1.02 billion. PMI previously had offered 150p per Vectura share.

Clarkson was up 2.0% after the shipping services provider reported a robust set of interim earnings, with strong trading across all areas of the business.

For the six months to June 30, revenue was GBP190.1 million, up 5.4%, GBP180.4 million last year, and pretax profit rose 31% to GBP27.3 million from GBP20.9 million.

The company declared an interim dividend of 27p, up 8% from 25p paid out at the halfway stage last year.

Elsewhere, Deliveroo was up 5.3% after Germany's Delivery Hero built a 5.1% stake in its UK rival, crossing the 5% threshold on Friday, according to a regulatory release on Monday. Delivery Hero was 0.1% lower in Frankfurt.

In China on Monday, the Shanghai Composite closed up 1.0%, while the Hang Seng index in Hong Kong was up 0.5%. Financial markets in Japan were closed on Monday for the Mountain Day holiday. The S&P/ASX 200 in Sydney finished flat.

Chinese factory inflation rose by more than expected in July, data showed Monday, as surging commodity prices offset government measures to temper costs.

The producer price index, which measures the cost of goods at the factory gate, rose to 9.0% on-year, the same as May, which was a 13-year high, according to the National Bureau of Statistics.

While the PPI remains elevated, consumer inflation ticked down to 1.0% in July, with officials stressing their work to stabilise prices in the wake of recent disasters including floods in central China and with companies appearing to absorb the increases instead of passing them on to consumers.

The pound was quoted at USD1.3887 early Monday, up from USD1.3862 at the London equities close Friday.

The euro was priced at USD1.1755, marginally lower from USD1.1760. Against the Japanese yen, the dollar was trading at JPY110.12, down from JPY110.30.

Brent oil was quoted at USD69.00 a barrel Monday morning, down sharply from USD70.92 late Friday. Gold was trading at USD1,745.26 an ounce, down from USD1,764.55.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.